Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169441 · ClinicalTrials.gov registry record
Lead Extract Study
A clinical trial, sponsored by St. Paul Heart Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT01169441: Completed study, sponsored by St. Paul Heart Clinic.
NCT01169441 is a clinical trial that has completed, run by St. Paul Heart Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01169441 has completed, sponsored by St. Paul Heart Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The recent expansion of indications for implantable cardioverter defibrillators (ICDs) has changed the population of patients being implanted. Younger and healthier patients are now being implanted for primary prevention of sudden cardiac death. Due to the younger population, the likelihood of the lead failing during the lifetime of the patient is higher and also more likely to need extraction. To reduce the risk of the lead extraction procedure and therefore reduce the number of abandon leads, ICD lead manufacturers are designing leads to offer improved chronic extractability to reduce the morbidity and mortality during these procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-05 |
What the finished NCT01169441 record still lists
NCT01169441 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01169441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01169441 about?
NCT01169441 is a clinical study titled "Lead Extract Study". The recent expansion of indications for implantable cardioverter defibrillators (ICDs) has changed the population of patients being implanted. Younger and healthier patients are now being implanted for primary prevention of sudden cardiac death. Due to the younger population, the likelihood of the l...
What is the current status of trial NCT01169441?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2006-11. Estimated completion is 2010-05.
Who is sponsoring clinical trial NCT01169441?
This trial is sponsored by St. Paul Heart Clinic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia